Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > Novartis CEO says U.S. exit from global health programmes to affect millions
    Headlines

    Novartis CEO says U.S. exit from global health programmes to affect millions

    Published by Global Banking & Finance Review®

    Posted on January 31, 2025

    1 min read

    Last updated: January 26, 2026

    The image features Novartis CEO Vas Narasimhan addressing concerns about the U.S. withdrawal from global health programs, emphasizing its impact on millions relying on critical health initiatives.
    Novartis CEO Vas Narasimhan discusses U.S. exit from global health programs - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:Public Healthfinancial managementcorporate governance

    Quick Summary

    Novartis CEO warns that US withdrawal from WHO could impact millions relying on health programs. Key initiatives like HIV/AIDS and malaria are at risk.

    Novartis CEO Warns U.S. Withdrawal from Health Programs Could Impact Millions

    FRANKFURT (Reuters) - The American CEO of Swiss drugmaker Novartis on Friday warned that the United States' exit from the World Health Organization and related programmes risks harming millions of people worldwide.

    "I don't think there's a lot of logic in stopping these programmes, (some of which were) actually started by Republican administrations, ... given the millions of people who rely on these programmes to get the medicines that they need," CEO Vas Narasimhan said at a news conference after the release of quarterly financial results.

    There is a lot of pressure on initiatives that have lost funding, including a U.S. push to fight HIV/AIDS and malaria abroad, he said.

    The CEO added the company and its own global commitments, such as work on neglected tropical diseases, were not affected.

    (Reporting by Ludwig Burger, editing by Thomas Seythal)

    Key Takeaways

    • •Novartis CEO warns of US exit from WHO.
    • •Millions may be affected by halted health programs.
    • •Programs at risk include HIV/AIDS and malaria initiatives.
    • •US withdrawal lacks logic, says CEO Vas Narasimhan.
    • •Novartis' commitments to global health remain unaffected.

    Frequently Asked Questions about Novartis CEO says U.S. exit from global health programmes to affect millions

    1What did the Novartis CEO say about the U.S. exit from health programs?

    The CEO warned that the U.S. exit from the World Health Organization and related programs risks harming millions of people who rely on these initiatives.

    2What specific health initiatives are at risk due to U.S. funding cuts?

    There is significant pressure on initiatives that have lost funding, particularly those aimed at fighting HIV/AIDS and malaria abroad.

    3How is Novartis affected by the U.S. withdrawal from global health programs?

    The CEO stated that Novartis' own global commitments, such as work on neglected tropical diseases, are not affected by the U.S. withdrawal.

    More from Headlines

    Explore more articles in the Headlines category

    Image for Two airports in Poland closed due to Russian strikes on Ukraine
    Two airports in Poland closed due to Russian strikes on Ukraine
    Image for Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Image for Trump says good talks ongoing on Ukraine
    Trump says good talks ongoing on Ukraine
    Image for France to rally aid for Lebanon as it warns truce gains remain fragile
    France to rally aid for Lebanon as it warns truce gains remain fragile
    Image for Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Olympics-Italy's president takes the tram in video tribute to Milan transport
    Olympics-Italy's president takes the tram in video tribute to Milan transport
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Image for Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    View All Headlines Posts
    Previous Headlines PostNorway police board ship seized on suspicion of Baltic Sea cable damage
    Next Headlines PostTaiwan says government departments should not use DeepSeek, citing security concerns